RPA
SANA icon

Redwood Park Advisors’s Sana Biotechnology SANA Stock Holding History

Redwood Park Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.9K Hold
7,140
– – 0.02% 147
2026
Q1 		$20.6K Hold
7,140
– – 0.01% 151
2025
Q4 		$29.1K Hold
7,140
– – 0.02% 136
2025
Q3 		$25.3K Buy
7,140
+240
+3% +$868 0.02% 140
2025
Q2 		$18.8K Buy
+6,900
New +$14.2K 0.01% 149

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Redwood Park Advisors's SANA Position: Q2 2026 in Review

Redwood Park Advisors held its Sana Biotechnology (SANA) position steady in Q2 2026 at 7,140 shares worth $24.9K. The position accounts for 0.02% of the portfolio, ranked #147.

Redwood Park Advisors first reported a position in SANA in Q2 2025 and has held it in 5 quarters since. The position peaked at $29.1K in Q4 2025. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Redwood Park Advisors held 7,140 shares of Sana Biotechnology worth $24.9K as of Q2 2026.
  • Redwood Park Advisors left its Sana Biotechnology share count unchanged in Q2 2026.
  • Sana Biotechnology made up 0.02% of Redwood Park Advisors's portfolio in Q2 2026, its #147 holding.
  • Redwood Park Advisors first reported a position in Sana Biotechnology in Q2 2025 and has held it in 5 quarters since.
  • Redwood Park Advisors's Sana Biotechnology position peaked at $29.1K in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Redwood Park Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.